Why is Sanofi India falling/rising?

As of 11-Sep, Sanofi India Ltd's stock price is currently at 5,076.00, reflecting a slight increase of 5.05 (0.1%). The stock has been gaining for the last two days, with a total return of 0.71% during this period. However, it has underperformed its sector by 0.37% today and has shown negative returns over the past week, month, and year, with declines of -0.80%, -0.70%, and -29.60%, respectively. The stock is trading below all key moving averages and has experienced a significant drop in delivery volume, indicating a decrease in investor participation. While the company boasts a high return on equity and low debt-to-equity ratio, its long-term growth prospects are hindered by declining net sales and operating profits, which have fallen by -8.57% and -5.45% over the last five years.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark Sensex, which has gained 1.03% over the past week and 1.17% over the past month. This underperformance is further highlighted by the stock's year-to-date decline of -16.78% compared to the Sensex's increase of 4.36%. The high institutional holdings suggest that knowledgeable investors are aware of the company's challenges, which may contribute to the stock's lack of upward momentum despite its recent minor gains. Overall, the combination of poor long-term growth, recent flat financial results, and declining investor interest paints a concerning picture for Sanofi India's stock performance.